HU193648B - Process for production of derivatives of furil-oxasolile acetic acid and medical preparatives containing those - Google Patents
Process for production of derivatives of furil-oxasolile acetic acid and medical preparatives containing those Download PDFInfo
- Publication number
- HU193648B HU193648B HU83658A HU65883A HU193648B HU 193648 B HU193648 B HU 193648B HU 83658 A HU83658 A HU 83658A HU 65883 A HU65883 A HU 65883A HU 193648 B HU193648 B HU 193648B
- Authority
- HU
- Hungary
- Prior art keywords
- formula
- furyl
- preparation
- acetic acid
- oxazol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Obesity (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57030921A JPS58148882A (ja) | 1982-02-26 | 1982-02-26 | フリルオキサゾリル酢酸誘導体及びその製法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HU193648B true HU193648B (en) | 1987-11-30 |
Family
ID=12317149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU83658A HU193648B (en) | 1982-02-26 | 1983-02-25 | Process for production of derivatives of furil-oxasolile acetic acid and medical preparatives containing those |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4642313A (enExample) |
| EP (1) | EP0087782B1 (enExample) |
| JP (1) | JPS58148882A (enExample) |
| KR (1) | KR900001423B1 (enExample) |
| AT (1) | ATE19879T1 (enExample) |
| BG (1) | BG39977A3 (enExample) |
| CA (1) | CA1194483A (enExample) |
| DE (1) | DE3363575D1 (enExample) |
| DK (1) | DK82583A (enExample) |
| ES (1) | ES520136A0 (enExample) |
| HK (1) | HK87188A (enExample) |
| HU (1) | HU193648B (enExample) |
| SG (1) | SG10688G (enExample) |
| SU (1) | SU1169536A3 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59152382A (ja) * | 1983-02-18 | 1984-08-31 | Tanabe Seiyaku Co Ltd | フリルオキサゾリル酢酸誘導体 |
| SE9302332D0 (sv) * | 1993-07-06 | 1993-07-06 | Ab Astra | New compounds |
| AU682792B2 (en) * | 1994-10-13 | 1997-10-16 | Cv Therapeutics, Inc. | Method of manufacturing non-absorbable synthetic sulfated polysaccharides |
| US7071174B1 (en) | 1994-10-13 | 2006-07-04 | Cv Therapeutics, Inc. | Method and composition for inhibiting cholesterol esterase |
| WO2002083111A2 (en) * | 2001-04-16 | 2002-10-24 | Tanabe Seiyaku Co., Ltd. | Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE32084B1 (en) * | 1967-06-07 | 1973-04-04 | Wyeth John & Brother Ltd | Thiazole derivatives |
| FI53314C (fi) * | 1967-06-14 | 1978-04-10 | Wyeth John & Brother Ltd | Foerfarande foer framstaellning av farmaceutiskt anvaendbar 2-(fenyleller p-klorfenyl) oxazol-4-yl (aettiksyra -acetatsalt eller -acetamid) |
| GB1245087A (en) * | 1967-10-26 | 1971-09-02 | Wyeth John & Brother Ltd | Heterocyclic compounds |
| US3578671A (en) * | 1967-11-06 | 1971-05-11 | Wyeth John & Brother Ltd | Oxazoles |
| FR2068418A1 (en) * | 1969-10-27 | 1971-08-27 | Innothera Lab Sa | 2-substd-5-amino isoxazole derivs |
| AR208400A1 (es) * | 1974-03-13 | 1976-12-27 | Yoshitomi Pharmaceutical | Un metodo para producir nuevos acidos 5-alcoxi-4-oxazolalcanoicos 2-substituidos y sus esteres |
| JPS51110039A (ja) * | 1975-02-28 | 1976-09-29 | Yoshitomi Pharmaceutical | Ketsuchushishitsutaishakaizenzai |
| GB1542315A (en) * | 1976-08-13 | 1979-03-14 | Wyeth John & Brother Ltd | Process for preparing oxazoles |
| JPS5677268A (en) * | 1979-11-28 | 1981-06-25 | Yoshitomi Pharmaceut Ind Ltd | Oxazoleacetic acid derivative |
| JPS57188587A (en) * | 1981-05-15 | 1982-11-19 | Tanabe Seiyaku Co Ltd | Thienyloxazolylacetic acid derivative and its preparation |
-
1982
- 1982-02-26 JP JP57030921A patent/JPS58148882A/ja active Granted
-
1983
- 1983-02-10 US US06/465,544 patent/US4642313A/en not_active Expired - Fee Related
- 1983-02-22 CA CA000422117A patent/CA1194483A/en not_active Expired
- 1983-02-23 DK DK82583A patent/DK82583A/da not_active Application Discontinuation
- 1983-02-24 BG BG059855A patent/BG39977A3/xx unknown
- 1983-02-25 DE DE8383101872T patent/DE3363575D1/de not_active Expired
- 1983-02-25 ES ES520136A patent/ES520136A0/es active Granted
- 1983-02-25 SU SU833555401A patent/SU1169536A3/ru active
- 1983-02-25 KR KR1019830000770A patent/KR900001423B1/ko not_active Expired
- 1983-02-25 AT AT83101872T patent/ATE19879T1/de active
- 1983-02-25 EP EP83101872A patent/EP0087782B1/en not_active Expired
- 1983-02-25 HU HU83658A patent/HU193648B/hu not_active IP Right Cessation
-
1988
- 1988-02-06 SG SG106/88A patent/SG10688G/en unknown
- 1988-10-27 HK HK871/88A patent/HK87188A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US4642313A (en) | 1987-02-10 |
| ES8403891A1 (es) | 1984-04-01 |
| HK87188A (en) | 1988-11-04 |
| DK82583D0 (da) | 1983-02-23 |
| JPS58148882A (ja) | 1983-09-05 |
| KR840003632A (ko) | 1984-09-15 |
| SU1169536A3 (ru) | 1985-07-23 |
| JPS635027B2 (enExample) | 1988-02-01 |
| CA1194483A (en) | 1985-10-01 |
| EP0087782A1 (en) | 1983-09-07 |
| KR900001423B1 (ko) | 1990-03-09 |
| DE3363575D1 (en) | 1986-06-26 |
| EP0087782B1 (en) | 1986-05-21 |
| SG10688G (en) | 1988-07-01 |
| ES520136A0 (es) | 1984-04-01 |
| BG39977A3 (en) | 1986-09-15 |
| ATE19879T1 (de) | 1986-06-15 |
| DK82583A (da) | 1983-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0025232B1 (en) | 4-(substituted thiazolyl)-3-hydroxy-3-pyrroline-2,5-dione compounds, processes for preparing and a pharmaceutical composition comprising the same | |
| KR20020008221A (ko) | 사람 퍼옥시좀 증식 활성화 수용체(ＰＰＡＲ)α효능제로서의 치환된 페닐프로피온산 유도체 | |
| US6096770A (en) | Anthranilic acid analogs | |
| EP0091726B1 (en) | 5-substituted 1,2,4-oxadiazole derivatives, their preparation and pharmaceutical compositions containing them | |
| EP2001844A2 (en) | Bicyclic carboxylic acid derivatives useful for treating metabolic disorders | |
| HU177559B (en) | Process for producing new n-aroyl or n-heteroaroyl-substituted-p-amino-alkylphenylalkane carboxylic acids,and esters,amides and physiologically acceptable salts thereof | |
| HU193648B (en) | Process for production of derivatives of furil-oxasolile acetic acid and medical preparatives containing those | |
| EP0096890B1 (en) | Oxazoleacetic acid derivatives, process for their production and compositions containing said derivatives | |
| US4496578A (en) | Antihypertensive sulfur-containing compounds | |
| DE69402004T2 (de) | Beta-mercapto-propanamidderivate verwendbar zur Behandlung kardiovaskularer Krankheiten oder Erkrankungen | |
| JPS5829950B2 (ja) | 環状イミノカルボン酸誘導体およびその塩類 | |
| US4535089A (en) | Alkyloxazolylacetic acid derivative for the treatment of hyperlipidemia | |
| US4460596A (en) | Thienyloxazolylacetic acid derivatives and process for preparing | |
| AU734786B2 (en) | Anthranilic acid analogs | |
| EP0316790A1 (en) | Rhodanine derivatives, a process for their preparation, pharmaceutical compositions and their use | |
| Moriya et al. | Synthesis of ethyl 2-(4-chlorophenyl)-5-(2-furyl)-4-oxazoleacetate, a hypolipidemic agent, and related compounds | |
| EP0120270B1 (en) | Furyloxazolylacetic acid derivative, processes for preparing same and pharmaceutical composition | |
| JPH08325264A (ja) | 新規２−芳香環置換−３−フェニルプロピオン酸またはアクリル酸誘導体 | |
| JPH08325250A (ja) | 新規置換フェノール誘導体 | |
| JPH0449B2 (enExample) | ||
| US4990524A (en) | 2-thiazolones in a method of treating a gastric ulcer | |
| KR960008245B1 (ko) | 로다닌 유도체 및 약제학적 조성물 | |
| JPS6048512B2 (ja) | 環状イミノカルボン酸誘導体およびその塩類 | |
| MXPA00001255A (en) | Anthranilic acid analogs | |
| ZA200600713B (en) | Device for fixing a longitudinal carrier to a bone fixing element |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HU90 | Patent valid on 900628 | ||
| HMM4 | Cancellation of final prot. due to non-payment of fee |